These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

54 related articles for article (PubMed ID: 3078836)

  • 1. Protective Activity of Inactivated Rabies Vaccine Using Flagellin-Based Adjuvant.
    Sokol OO; Nikitin NA; Evtushenko EA; Karpova OV; Matveeva IN; Gryn SA; Popova VM; Ivanov IV; Fedorov YN; Litenkova IY
    Biochemistry (Mosc); 2024 Mar; 89(3):574-582. PubMed ID: 38648774
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pre- and post-exposure safety and efficacy of attenuated rabies virus vaccines are enhanced by their expression of IFNγ.
    Barkhouse DA; Faber M; Hooper DC
    Virology; 2015 Jan; 474():174-80. PubMed ID: 25463615
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lyssaviruses: current trends.
    Nadin-Davis SA; Fehlner-Gardiner C
    Adv Virus Res; 2008; 71():207-50. PubMed ID: 18585530
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antigenic and molecular characterization of field and vaccine rabies virus strains in the Russian Federation.
    Metlin AE; Rybakov SS; Gruzdev KN; Neuvonen E; Cox J; Huovilainen A
    Dev Biol (Basel); 2006; 125():33-7. PubMed ID: 16878458
    [No Abstract]   [Full Text] [Related]  

  • 5. [Health ethology of the fox and antirabies vaccine in the Italian experience].
    Balbo T
    Parassitologia; 1988; 30(1):13-7. PubMed ID: 3268766
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incorporating B cell activating factor (BAFF) into the membrane of rabies virus (RABV) particles improves the speed and magnitude of vaccine-induced antibody responses.
    Plummer JR; McGettigan JP
    PLoS Negl Trop Dis; 2019 Nov; 13(11):e0007800. PubMed ID: 31725816
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rabies vaccine (Babeş strain of fixed rabies virus) inactivated with betapropiolactone.
    Toacsen E; Serban O; Moraru S
    Arch Roum Pathol Exp Microbiol; 1981; 40(4):333-9. PubMed ID: 7340722
    [No Abstract]   [Full Text] [Related]  

  • 8. [Humoral immune response as a laboratory criterion for evaluation of the effectiveness of rabies vaccines].
    Seroka D; Wysokińska T
    Med Dosw Mikrobiol; 1982; 34(1-2):61-71. PubMed ID: 7144329
    [No Abstract]   [Full Text] [Related]  

  • 9. Rabies vaccine: traditional and novel approaches.
    Kieny MP; Desmettre P; Soulebot JP; Lathe R
    Prog Vet Microbiol Immunol; 1987; 3():73-111. PubMed ID: 3078836
    [No Abstract]   [Full Text] [Related]  

  • 10. New developments in the pre- and post-exposure treatment of rabies.
    Dietzschold B; Ertl HC
    Crit Rev Immunol; 1991; 10(5):427-39. PubMed ID: 2021425
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New approaches to the development of live attenuated rabies vaccines.
    Dietzschold B; Schnell MJ
    Hybrid Hybridomics; 2002 Apr; 21(2):129-34. PubMed ID: 12031103
    [TBL] [Abstract][Full Text] [Related]  

  • 12. From brain passage to cell adaptation: the road of human rabies vaccine development.
    Wu X; Smith TG; Rupprecht CE
    Expert Rev Vaccines; 2011 Nov; 10(11):1597-608. PubMed ID: 22043958
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.